AngioDynamics, Inc.

AngioDynamics, Inc. is a diversified medical technology company that designs, manufactures, and sells products and technologies to aid clinicians in treating patients with cardiovascular disease and cancer diagnoses. The company's strategy focuses on innovative research and development, expanding clinical and regulatory pathways, and customer-centric sales. AngioDynamics was founded in Queensbury, N.Y., U.S., in 1988 and began manufacturing and shipping products in the early 1990s. The company is headquartered in Latham, N.Y., with manufacturing primarily in Queensbury. Initially, it focused on products for interventional radiology, becoming known for diagnostic catheters for non-coronary angiography and thrombolytic delivery systems. Over the years, AngioDynamics grew through acquisitions, adding various product lines. Key acquisitions include RITA Medical Systems in January 2007, Oncobionic in May 2008, the assets of Diomed in June 2008, Vortex Medical, Inc. in October 2012, the assets of Microsulis Medical Limited in January 2013, and Clinical Devices in August 2013. These acquisitions brought in ablation and NanoKnife systems, vascular access products, angiographic products and accessories, dialysis products, drainage products, thrombolytic products, embolization products, and venous products. In September 2018, the company acquired RadiaDyne, which included endorectal and vaginal balloons. On October 2, 2019, AngioDynamics acquired Eximo Medical, Ltd. and its proprietary 355nm laser atherectomy technology (now Auryon) for Peripheral Artery Disease. On December 17, 2019, the company acquired the C3 Wave tip location asset from Medical Components Inc. On July 27, 2021, AngioDynamics acquired the Camaro Support Catheter asset from QX Medical, LLC. The company sold its Fluid Management business (acquired in May 2012) to Medline Industries, Inc. in May 2019 and the BioSentry product line (acquired in August 2018) to Merit Medical Systems, Inc. in June 2023.